OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Randall Bateman

2 Projects | 1 Researchers | $1,150,000 Invested

2026

Washington University in St. Louis

Randall Bateman, MD

Consortium for Biomedical Research and Artificial Intelligence in Neurodegeneration (C-BRAIN)

  • Funding Amount: $1,000,000
  • Organization Type:
  • Program: Drug Discovery
  • Target: Multi-Target
  • Status: Active

Washington University in St. Louis

Randall Bateman, MD

2026 Annual Goodes Prize for Excellence in Alzheimer's Drug Discovery

  • Funding Amount: $150,000
  • Organization Type:
  • Program: Drug Discovery
  • Status: Active